Sanis Health Losartan / Losartan-HCTZ Product Recall (2021-09-10)

Issue: Product Safety

Category: Drugs

Audience: General Public, Healthcare Professionals, Hospitals

Department: Health Canada

Alert type: Drug Recall

Hazard classification: Type I

Losartan 25 mg Tablet

Lot or serial number	Brand name	Companies	DIN, NPN, DIN-HIM	Dosage form	Strength
KS7557, KX6499, LB3650	Losartan/HCTZ 100 mg / 50 mg Tablet	Recalling Firm Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA Marketing Authorization Holder Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA	DIN 02427648	Tablet	Hydrochlorothiazide 50mg, Losartan Potassium 100mg
KS9114, LB1656, LG7830	Losartan/HCTZ 100 mg / 12.5 mg Tablet	Recalling Firm Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA Marketing Authorization Holder Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA	DIN 02427656	Tablet	Hydrochlorothiazide 12.5mg, Losartan Potassium 100mg
KS3078, KU3077, KZ7521	Losartan/HCTZ 100 mg / 25 mg Tablet	Recalling Firm Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA Marketing Authorization Holder Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA	DIN 02427664	Tablet	Hydrochlorothiazide 25mg, Losartan Potassium 100mg
KS1007, KS8836, KY7469, LB2316	Losartan 50 mg Tablet	Recalling Firm Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA Marketing Authorization Holder Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA	DIN 02388871	Tablet	Losartan Potassium 50mg
KS9031, KY5728, LJ2274	Losartan 100 mg Tablet	Recalling Firm Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA Marketing Authorization Holder Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA	DIN 02388898	Tablet	Losartan Potassium 100mg
KS3239, KV8086, LH0370	Losartan 25 mg Tablet	Recalling Firm Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA Marketing Authorization Holder Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA	DIN 02388863	Tablet	Losartan Potassium 25mg

Losartan 25 mg Tablet
Losartan 50 mg Tablet
Losartan 100 mg Tablet
Losartan/HCTZ 100 mg / 12.5 mg Tablet
Losartan/HCTZ 100 mg / 25 mg Tablet
Losartan/HCTZ 100 mg / 50 mg Tablet

Presence of 5-(azidomethyl)-2-butyl-4-chloro-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole impurity

Retailers

https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php

Allergies Food poisoning Children & Infants Medicine & Drugs Vehicles

Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.

You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.

Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.

Recall Monitor is not endorsed by, or is an official product of the Government of Canada.

Made with in Vancouver, BC

Sanis Health Losartan / Losartan-HCTZ Product Recall (2021-09-10)
Health Products
Sep 10th, 2021 @ 12:00 AM

Basic Details

Summary

Product

Products

Introduction

Reason

Depth of distribution

For more information

About

Why subscribe?

Social

Recall Monitor

Sanis Health Losartan / Losartan-HCTZ Product Recall (2021-09-10)Health ProductsSep 10th, 2021 @ 12:00 AM